This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Low molecular weight heparin prophylaxis for placenta-mediated complications in women with F2G20210A mutation, Russian journal of hematology and transfusiology, September 2021, National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation,
DOI: 10.35754/0234-5730-2021-66-2-231-241.
You can read the full text:
The following have contributed to this page
